Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups

Canadian Journal of Surgery

Volumn 42, Issue 3, 1999, Pages 190-199

  Waddell, Andrea E ^a   Davis, Aileen M ^a   Ahn, Henry ^a   Wunder, Jay S ^a   Blackstein, Martin E ^a   Bell, Robert S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE BIOPSY; BONE CANCER; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHONDROSARCOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; HUMAN; LEIOMYOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0033029953     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bacci G, Avella M, Picci P, Dallari D, Malaguti C, Biagini R, et al. Primary chemotherapy and delayed surgery for malignant fibrous histiocytoma of bone in the extremity [review]. Tumori 1990;76(6):537-42.
2. Johnson S, Tetu B, Ayala AG, Chawla SP. Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study. Cancer 1986;58(2): 278-86.
3. Jundt G, Moll C, Nidecker A, Schilt R, Remagen W. Primary leiomyosarcoma of bone: report of eight cases. Hum Pathol 1994;25(11):1205-12.
4. Taconis WK, van Rijssel TG. Fibrosarcoma of long bones. A study of the significance of areas of malignant fibrous histiocytoma. J Bone Joint Surg [Br] 1985;67(1):111-6.
5. Campanacci M, Olmi R. Fibrosarcoma of bone. A study of 114 cases. Ital J Orthop Traumatol 1977;3(2):199-206.
6. Dahlin DC, Unni KK, Matsuno T. Malignant (fibrous) histiocytoma of bone - fact or fancy? Cancer 1977; 39(4):1508-16.
7. Earl HM, Pringle J, Kemp H, Morittu L, Miles D, Souhami R. Chemotherapy of malignant fibrous histiocytoma of bone. Ann Oncol 1993;4(5):409-15.
8. Volpe R, Mazabraud A. Hemangio-endothelioma (angiosarcoma) of bone: A distinct pathologic entity with an unpredictable course? Cancer 1982;49 (4):727-36.
9. Berlin O, Angervall L, Kindblom L, Berlin IC, Stener B. Primary leiomyosarcoma of bone. A clinical, radiographic, pathologic-anatomic, and prognostic study of 16 cases [review]. Skeletal Radiol 1987;16(5):364-76.
10. Mercuri M, Picci P, Campanacci L, Rulli E. Dedifferentiated chondrosarcoma. Skeletal Radiol 1995;24(6): 409-16.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
13. den Heeten GJ, Schraffordt-Koops H, Kamps WA, Oosterhuis JW, Sleijfer DT, Oldhoff J. Treatment of malignant fibrous histiocytoma of bone. A plea for primary chemotherapy. Cancer 1985;56(1):37-40.
14. Bacci G, Springfield D, Capanna R, Picci P, Bertoni F, Campanacci M. Adjuvant chemotherapy for malignant fibrous histiocytoma in the femur and tibia. J Bone Joint Surg [Am] 1985;67 (4):620-5.
15. Bertoni F, Present D, Bacchini P, Picci P, Pignatti G, Gherlinzoni F, et al. Dedifferentiated peripheral chondrosarcomas. A report of seven cases. Cancer 1989;63(10):2054-9.
16. Myers JL, Arocho J, Bernreuter W, Dunham W, Mazur MT. Leiomyosarcoma of bone. A clinicopathologic, immunohistochemical, and ultrastructural study of five cases. Cancer 1991; 67(4):1051-6.
17. Ham SJ, Hoekstra HJ, van der Graaf WTA, Kamps WA, Molenaar WM, Schraffordt-Koops H. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone. J Clin Oncol 1996;14(2):490-6.
18. Ghandur-Mnaymneh L, Zych G, Mnaymneh W. Primary malignant fibrous histiocytoma of bone: report of six cases with ultrastructural study and analysis of the literature. Cancer 1982;49(4):698-707.
19. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314(25):1600-6.
20. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 1992;69(3): 698-708.
21. Bramwell VHC. The role of chemotherapy in osteogenic sarcoma [review]. Crit Rev Oncol Hematol 1995;20(1-2):61-85.
22. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memoral Sloan-Kettering experience [see comment]. J Clin Oncol 1992;10(1):5-15. Comment in J Clin Oncol 1992;10(1):1-2.
23. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memoral Sloan-Kettering experience [see comment]. J Clin Oncol 1992;10(1):5-15. Comment in J Clin Oncol 1992;10(1):1-2.
24. Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell V, et al. A randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup [see comment]. Lancet 1997;350:911-7. Comment in Lancet 1997;350:900-1.
25. Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell V, et al. A randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup [see comment]. Lancet 1997;350:911-7. Comment in Lancet 1997;350:900-1.
26. Capanna R, Bertoni F, Bacchini P, Bacci G, Guerra A, Campanacci M. Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer 1984;54(1):177-87.
27. Weiner M, Sedlis M, Johnston AD, Dick HM, Wolff JA. Adjuvant chemotherapy of malignant fibrous histiocytoma of bone. Cancer 1983;51 (1):25-9.
28. Urban C, Rosen G, Huvos AG, Caparros B, Cacavio A, Nirenberg A. Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases. Cancer 1983;51(5):795-802.